Association of Germline Variation in Driver Genes with Breast Cancer Risk in Chilean Population.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
08 Nov 2023
Historique:
received: 27 09 2023
revised: 02 11 2023
accepted: 04 11 2023
medline: 27 11 2023
pubmed: 25 11 2023
entrez: 25 11 2023
Statut: epublish

Résumé

Cancer is a genomic disease, with driver mutations contributing to tumorigenesis. These potentially heritable variants influence risk and underlie familial breast cancer (BC). This study evaluated associations between BC risk and 13 SNPs in driver genes

Identifiants

pubmed: 38003265
pii: ijms242216076
doi: 10.3390/ijms242216076
pmc: PMC10671568
pii:
doi:

Substances chimiques

BRCA1 protein, human 0
BRCA1 Protein 0
BRCA2 protein, human 0
BRCA2 Protein 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fondo Nacional de Desarrollo Científico y Tecnológico
ID : 1200049
Organisme : Fondo Nacional de Desarrollo Científico y Tecnológico
ID : 1160889
Organisme : ANID Subvención a Instalación en la Academia Convocatoria año 2022 (SIA)
ID : 85220068

Références

Nature. 2012 May 16;486(7403):400-4
pubmed: 22722201
Fam Cancer. 2022 Oct;21(4):441-451
pubmed: 35075588
BMC Cancer. 2016 Feb 26;16:165
pubmed: 26920143
Cancer. 1992 Sep 15;70(6 Suppl):1747-54
pubmed: 1516030
Front Oncol. 2022 Jun 09;12:891824
pubmed: 35756641
Cancers (Basel). 2020 Jan 20;12(1):
pubmed: 31968594
Nat Rev Genet. 2013 May;14(5):321-32
pubmed: 23594910
Genome Med. 2018 Mar 28;10(1):25
pubmed: 29592813
Nat Rev Cancer. 2020 Oct;20(10):555-572
pubmed: 32778778
BMC Cancer. 2006 Jan 26;6:25
pubmed: 16438724
J Pathol. 2015 Mar;235(4):571-80
pubmed: 25424858
Front Oncol. 2021 Jul 07;11:599719
pubmed: 34307117
N Engl J Med. 2010 Oct 14;363(16):1532-43
pubmed: 20942669
Oncogene. 1997 Apr 24;14(16):1891-9
pubmed: 9150356
Biomed Res Int. 2013;2013:747318
pubmed: 23586058
Cell Oncol (Dordr). 2023 Oct;46(5):1213-1234
pubmed: 37166744
Cancer Res. 2008 Mar 15;68(6):1675-82
pubmed: 18339846
Sci Rep. 2013 Oct 02;3:2650
pubmed: 24084849
Breast Cancer Res. 2002;4(5):179-81
pubmed: 12223120
Oncotarget. 2017 Jun 29;8(43):74233-74243
pubmed: 29088781
Science. 2011 Mar 25;331(6024):1553-8
pubmed: 21436442
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Cancer Causes Control. 2017 Apr;28(4):259-271
pubmed: 28238063
Oncogene. 2000 Sep 7;19(38):4396-404
pubmed: 10980615
Nature. 2012 Jun 20;486(7403):405-9
pubmed: 22722202
Nature. 2010 Apr 15;464(7291):993-8
pubmed: 20393554
Biol Res. 2022 May 31;55(1):20
pubmed: 35637532
Nature. 2009 Apr 9;458(7239):719-24
pubmed: 19360079
Biol Res. 2017 Oct 6;50(1):35
pubmed: 28985766
J Natl Cancer Inst. 2000 Sep 6;92(17):1388-402
pubmed: 10974075
Genes Cancer. 2013 Nov;4(11-12):419-26
pubmed: 24386504
Cell. 2018 Aug 9;174(4):1034-1035
pubmed: 30096302
Front Biosci (Landmark Ed). 2022 May 23;27(5):167
pubmed: 35638434
Ann Oncol. 2013 Feb;24(2):384-390
pubmed: 23022998
Oncotarget. 2017 Dec 5;8(70):115018-115027
pubmed: 29383138
Am J Hum Genet. 1991 Feb;48(2):232-42
pubmed: 1990835
Mol Biosyst. 2010 Nov;6(11):2332-8
pubmed: 20862427
Nat Genet. 2013 Oct;45(10):1113-20
pubmed: 24071849
Clin Cancer Res. 2003 Mar;9(3):1039-46
pubmed: 12631604
Nature. 2012 Jun 10;486(7403):353-60
pubmed: 22722193
Mol Cancer. 2009 Nov 27;8:111
pubmed: 19943940
Nature. 2012 Apr 04;486(7403):395-9
pubmed: 22495314
J Clin Oncol. 2002 May 1;20(9):2319-26
pubmed: 11981003
Oncol Lett. 2022 Feb;23(2):68
pubmed: 35069877
Mol Biol Rep. 2022 Aug;49(8):7531-7539
pubmed: 35596815
Int J Cancer. 2019 Nov 15;145(10):2692-2700
pubmed: 30927251
Cell Res. 2018 Jul;28(7):719-729
pubmed: 29795445
Oncol Lett. 2015 Sep;10(3):1709-1715
pubmed: 26622737
Leukemia. 2014 Sep;28(9):1844-50
pubmed: 24535406
Breast Cancer Res. 2009;11(2):301
pubmed: 19344493
Nat Protoc. 2006;1(2):581-5
pubmed: 17406285

Auteurs

Sebastián Morales-Pison (S)

Centro de Oncología de Precisión (COP), Facultad de Medicina y Ciencias de la Salud, Universidad Mayor, Las Condes, Santiago 7560908, Chile.

Julio C Tapia (JC)

Laboratorio de Transformación Celular, Programa de Biología Celular y Molecular, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Independencia, Santiago 783090, Chile.

Sarai Morales-González (S)

Laboratorio de Genética Humana, Programa de Genética Humana, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Independencia, Santiago 783090, Chile.

Edio Maldonado (E)

Programa de Biología Celular y Molecular, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Independencia, Santiago 783090, Chile.

Mónica Acuña (M)

Laboratorio de Genética Humana, Programa de Genética Humana, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Independencia, Santiago 783090, Chile.

Gloria M Calaf (GM)

Instituto de Alta Investigación, Universidad de Tarapacá, Arica 1010069, Chile.

Lilian Jara (L)

Laboratorio de Genética Humana, Programa de Genética Humana, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Independencia, Santiago 783090, Chile.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH